Norbert Gleicher

Last updated
Norbert Gleicher
Born (1948-08-20) August 20, 1948 (age 76)
Kraków, Poland
NationalityAmerican
Alma mater Medical University of Vienna
Known forFounding the Center for Human Reproduction (CHR)
Children2
Scientific career
FieldsReproductive medicine
Institutions Center for Human Reproduction (CHR)

Norbert Gleicher (born August 20, 1948) is an American obstetrician-gynecologist active in obstetrical practice, in vitro fertilization, reproductive endocrinology, and reproductive immunology. [1] He is a fellow of the American College of Obstetricians and Gynecologists (FACOG) and the American College of Surgeons (ACS) and currently serves as president, medical director and chief scientist of the Center for Human Reproduction (CHR) in New York City, a clinical fertility center that he founded in 1981. Simultaneously, he is President of the Foundation for Reproductive Medicine, a not-for-profit research foundation. [2] Gleicher maintains additional academic appointments at Rockefeller University, and Medical University of Vienna. [3]

Contents

Early life and education

Gleicher was born in the Polish city of Kraków. [1] In his youth he moved to Vienna, the capital of Austria, where he began his medical studies at the Medical University of Vienna in 1966. He completed his medical degree and rotating internship at the Sackler Medical School of Tel Aviv University in 1974. He later moved to New York City for a 6-month fellowship in immunology. There he completed his residency in obstetrics and gynecology in 1979 at the Mount Sinai Medical Center. During his residency he also maintained a grant-funded research laboratory, mostly pursuing research in reproductive immunology. While still a chief resident, Gleicher organized at Mount Sinai Medical Center an international congress on reproductive immunology, which led to the formation of the American Society of Reproductive Immunology (ASRI), with him being elected as the society's vice-president, and with the immunology conference becoming an annual event under the society's sponsorship. [4] He was awarded the Dr. Solomon Silver Award in Clinical Medicine for his "ability to apply the advance in research to the practice of clinical medicine". [5]

Career

Beginnings

In 1979, Gleicher was appointed assistant professor in the Department of Obstetrics and Gynecology at Mount Sinai, [6] division director of the Division of Reproductive Immunology and director of undergraduate (medical student affairs) and graduate education (residency program) in the department. He served in all of these functions until 1981. [5]

Recruited to Chicago in 1981 as chairman of obstetrics and gynecology at Mount Sinai Hospital and professor of obstetrics and gynecology and immunology/microbiology at Rush Medical College, [7] he was put in charge of rebuilding an academic teaching department in the inner city. His department established the first in vitro fertilization (IVF) program in the city of Chicago and the Midwest. [8] Gleicher traveled for training to René Frydman's Paris-based IVF program in preparation for the program's establishment. As the number of programs in the U.S. was still minuscule then, The Chicago Tribune dedicated a two-day series of articles to its opening. [9] In 1982 was appointed as founding editor-in-chief of The Journal of In Vitro Fertilization and Embryo Transfer (JIVF-ET), holding this position for approximately 20 years. [3] In 1991 Gleicher was awarded Austrian Decoration for Science and Art for his work.

Center for Human Reproduction

After 10 years of building a department, Gleicher resigned his chairmanship at Mount Sinai to concentrate on management of a rapidly growing IVF center, the Center for Human Reproduction (CHR). [10] [11] [12] By the end of 1999, Gleicher was in charge of IVF centers in Chicago and New York City, splitting his time each week between the two cities. In 2003, he sold the Chicago operations, and moved full-time back to New York City, where he continues to pursue both clinical care and research. [13] [14]

While maintaining his role in clinical patient care and research at the Center for Human Reproduction in New York, Gleicher has continued his academic work as a professor or adjunct professor at educational institutions such as Yale University, [15] New York University, Rockefeller University, [16] and the Medical University of Vienna. [3]

Gleicher is a member of the American College of Obstetricians and Gynecologists, the American Society for Reproductive Medicine, and the European Society of Human Reproduction and Embryology, among other institutions related to reproductive health and general medicine. As a speaker, Gleicher has lectured at major events worldwide. [3] In 2009, he was commissioned to deliver the Patrick Steptoe Memorial Lecture in honour of the prominent British obstetrician and gynecologist before the British Fertility Society. [17]

Publications

Since the 1970s, Gleicher has published hundreds of scientific articles, abstracts and book chapters on reproductive endocrinology and infertility. He was one of the founders of the American Journal of Reproductive Immunology, where he also served as editor-in-chief. For 30 years, he was editor of the Journal of In Vitro Fertilization and Embryo Transfer, now known as the Journal of Assisted Reproduction and Genetics. [5] Other publications in which he served as editor or member of the editorial board include The Mount Sinai Journal of Medicine, International Journal of Obstetrics and Gynecology, Asian Pacific Journal of Reproduction and PLOS One, among others. [3]

Major research contributions

DHEA controversy

Gleicher, in collaboration with his CHR colleague David H. Barad, introduced androgen supplementation by way of dehydroepiandrosterone (DHEA), to improve in vitro fertilization (IVF) outcomes in women with diminished ovarian reserve in 2005. [22] However, none of his studies used randomized, controlled trials; results have been mixed for researchers who did. [23]

Gleicher has been criticized for recommending his own brand of DHEA to his patients without always informing them that he owns the brand. His brand costs much more than competing brands. [23]

Personal life

Gleicher is divorced and the father of two daughters. In 2019, Gleicher was the subject of a social profile in The New York Times. He lives on the Upper East Side of Manhattan. [1]

Related Research Articles

Reproductive technology encompasses all current and anticipated uses of technology in human and animal reproduction, including assisted reproductive technology (ART), contraception and others. It is also termed Assisted Reproductive Technology, where it entails an array of appliances and procedures that enable the realization of safe, improved and healthier reproduction. While this is not true of all people, for an array of married couples, the ability to have children is vital. But through the technology, infertile couples have been provided with options that would allow them to conceive children.

<span class="mw-page-title-main">Georgeanna Seegar Jones</span> American gynecologist

Georgeanna Seegar Jones was an American reproductive endocrinologist who with her husband, Howard W. Jones, pioneered in vitro fertilization in the United States.

Poor ovarian reserve is a condition of low fertility characterized by 1): low numbers of remaining oocytes in the ovaries or 2) possibly impaired preantral oocyte development or recruitment. Recent research suggests that premature ovarian aging and premature ovarian failure may represent a continuum of premature ovarian senescence. It is usually accompanied by high FSH levels.

Carlos Sueldo is a physician and professor of obstetrics and gynaecology (OB/GYN) for the University of California, San Francisco. Dr. Sueldo is also the founder (1984) and present Director of the in vitro fertilization IVF Fertility Center. Dr. Sueldo concurrently serves as the Scientific Director at the Center for Gynecology and Reproduction (CEGYR) in Buenos Aires, Argentina, and is a founding board member of the World Endometriosis Research Foundation.

<span class="mw-page-title-main">John Buster</span> American physician

John Edmond Buster is an American physician who, while working at the University of California at Los Angeles School of Medicine, directed the research team that performed the first embryo transfer from one woman to another resulting in a live birth. It was performed at the Harbor-UCLA Medical Center, reported in July 1983, and culminated in the announcement of the birth on February 3, 1984. In the procedure, an embryo that was just beginning to develop was transferred from the woman in whom it had been conceived by artificial insemination to another woman who gave birth to the infant 38 weeks later. The sperm used in the artificial insemination came from the husband of the woman who bore the baby.

Reproductive surgery is surgery in the field of reproductive medicine. It can be used for contraception, e.g. in vasectomy, wherein the vasa deferentia of a male are severed, but is also used plentifully in assisted reproductive technology. Reproductive surgery is generally divided into three categories: surgery for infertility, in vitro fertilization, and fertility preservation.

The following outline is provided as an overview of and topical guide to obstetrics:

John Charles Rock was an American obstetrician and gynecologist. He is best known for the major role he played in the development of the first birth control pill.

Inna Berin is a Russian-American obstetrician and gynecologist, specializing in reproductive endocrinology and infertility at the Fertility Institute of New Jersey and New York. Dr. Berin has authored several scientific publications in the field of reproductive endocrinology and infertility.

Sandra Ann Carson is an American obstetrician who is the principal innovator of the first artificial human ovary. This innovation was reported in the Journal of Assisted Reproduction and Genetics, and recognized by Time magazine as one of the top 10 medical breakthroughs in 2010.

Female fertility is affected by age and is a major fertility factor for women. A woman's fertility is in generally good quality from the late teens to early thirties, although it declines gradually over time. Around 35, fertility is noted to decline at a more rapid rate. At age 45, a woman starting to try to conceive will have no live birth in 50–80 percent of cases. Menopause, or the cessation of menstrual periods, generally occurs in the 40s and 50s and marks the cessation of fertility, although age-related infertility can occur before then. The relationship between age and female fertility is sometimes referred to as a woman's "biological clock."

Abraham Albert "Al" Yuzpe is a Canadian obstetrician-gynecologist known for his work on human fertility and emergency contraception. The Yuzpe regimen, named after him, is a method of reducing potential unwanted pregnancies, including pregnancy from rape. He published the first studies demonstrating the method's safety and efficacy in 1974.

<span class="mw-page-title-main">Howard W. Jones</span> American physician (1910–2015)

Howard Wilbur Jones, Jr. was an American gynecological surgeon and in vitro fertilization (IVF) specialist. Jones and his wife, Georgeanna Seegar Jones, were two of the earliest reproductive medicine specialists in the United States. They established the reproductive medicine center that was responsible for the birth of the first IVF baby in the U.S. He wrote articles on the beginning of human personhood and testified before legislators on the same subject. He was one of the early physicians to perform sex reassignment surgeries.

Alan H. DeCherney is an Obstetrician and Gynecologist who specializes in reproductive endocrinology & infertility. He is experienced in reproductive and endocrinology, infertility, and reproductive genetics.

Peter C. Klatsky is a Doctor of Medicine specialized in reproductive endocrinology and infertility and an assistant professor at the Albert Einstein College of Medicine. Klatsky who is board certified in his specialty as well as in obstetrics and gynaecology, is also the Founder and CEO of Spring Fertility Management Llc, a San Francisco Bay Area fertility company. Klatsky is a member of the Council on Foreign Relations, a nonprofit think tank specializing in U.S. foreign policy and international affairs.

Miriam Friedman Menkin, née Miriam Friedman, was an American scientist who was most famous for her in vitro fertilization (IVF) research with John Rock. In February 1944, she became the first person to conceive human life outside of the body.

Alexander M. Feskov is a Ukrainian physician, reproductive scientist, and ultrasonographer who specialises in reproductive technology and fertility treatment.

The Center for Human Reproduction(CHR) is a fertility center located in New York City. It was founded by the obstetrician-gynecologist Norbert Gleicher in 1981.

Duru Shah is a Mumbai-based gynaecologist academic and women activist. She is the Founder President of the PCOS Society, India and a promoter of adolescent girls and women's health and infertility in India. Shah is also the promoter of Metropolis Healthcare Ltd. She is also a Consultant ObGyn.: Breach Candy Hospital, Jaslok Hospital, Mumbai.

Markku Tapio Seppälä is a Finnish physician specialising in obstetrics and gynecology. He graduated with a licentiate in medicine in 1964 and a doctorate in medicine and surgery in 1965. During his research activities that began in 1962, Seppälä has published approx. 500 peer-reviewed studies in international series, including collaborations with two Nobel Prize winners in medicine or physiology. His other scholarly output includes 5 books, and around 100 review articles, securing him international acclaim and positioning him among the top researchers in his field as per the Science Citation Index (SCI) in 2002. Seppälä was part of the team that delivered Finland's first IVF baby in 1984. Seppälä was awarded the Matti Äyräpää prize in 1981 for his research on fetal development proteins.

References

  1. 1 2 3 Boncompagni, Tatiana (2019-01-18). "How Norbert Gleicher, Fertility Expert, Spends His Sundays". The New York Times. ISSN   0362-4331 . Retrieved 2020-04-19.
  2. ↑ "FRM 2018 Conference Chairs". Translational Reproductive Biology and Clinical Reproductive Endocrinology. Retrieved 2020-04-19.
  3. 1 2 3 4 5 Norbert Gleicher MD Curriculum. New York: Center for Human Reproduction. 2019.
  4. ↑ "Gleicher Norbert". IVF-Worldwide . Retrieved 2020-04-30.
  5. 1 2 3 "Dr. Norbert Gleicher". The 5th International Congress on Cardiac Problems in Pregnancy. Retrieved 2020-04-20.
  6. ↑ Altchek, Albert; Deligdisch, Liane (2012-12-06). The Uterus: Pathology, Diagnosis, and Management. Springer Science & Business Media. ISBN   978-1-4613-9086-2.
  7. ↑ Giglia, R. V.; Gleicher, Norbert; Mayden, K. L. (2012-12-06). A Practical Guide to Real-Time Office Sonography in Obstetrics and Gynecology. Springer Science & Business Media. ISBN   978-1-4615-8348-6.
  8. ↑ Gorner, Peter (1985-04-14). "Making Babies". Chicago Tribune. Retrieved 2018-12-28.
  9. ↑ Van, Jon (1986-06-26). "In Vitro fertilization continues to develop". Sun Sentinel. Retrieved 2020-04-19.
  10. ↑ Knapton, Sarah (2015-11-22). "New fertility test warns women if they are running out of eggs". The Telegraph. ISSN   0307-1235 . Retrieved 2020-04-19.
  11. ↑ Prado, Victor (2019-10-19). "Are Pricey Fertility Treatments Helping Women Have Babies...Or Preying On Them?". Women's Health. Retrieved 2020-04-19.
  12. ↑ Reddy, Sumathi (2014-04-28). "Fertility Study Warns of Risks From Multiple Births". The Wall Street Journal. ISSN   0099-9660 . Retrieved 2020-04-20.
  13. ↑ Pollack, Andrew (2014-07-11). "Fertility Clinics Scan for the Strongest Embryo". The New York Times. ISSN   0362-4331 . Retrieved 2020-04-19.
  14. ↑ Devlin, Kate (2008-07-07). "Having twins no more dangerous than two single births". The Telegraph. ISSN   0307-1235 . Retrieved 2020-04-19.
  15. ↑ Muntz, Michelle. "New form of in vitro fertilization stirs debate". St. Louis Post. Retrieved 2020-04-19.
  16. ↑ "Why a gentler, less costly approach to IVF remains unpopular". Medical Xpress. 2019-01-21. Retrieved 2020-04-20.
  17. ↑ "Eponymous Lectures". British Fertility Society. Retrieved 2020-04-20.
  18. ↑ Gleicher, Norbert; Friberg, Jan; Fullan, Neil; Giglia, RobertV.; Mayden, Kara; Kesky, Tom; Siegel, Israel (August 1983). "Egg Retrieval for In Vitro Fertilisation by Sonographycally Controlled Vaginal Culdocentesis". The Lancet. 322 (8348): 508–509. doi:10.1016/S0140-6736(83)90530-5. ISSN   0140-6736. PMID   6136659. S2CID   20229808.
  19. ↑ Confino, Edmond; Frieberg, Jan; Gleicher, Norbert (April 1989). "Preliminary Experience with Transcervical Balloon Tuboplasty". Obstetrical & Gynecological Survey. 44 (4): 288–289. doi:10.1097/00006254-198904000-00023. ISSN   0029-7828. PMID   3407695.
  20. ↑ Kotulak, Ronald. "Mt. Sinai is the first hospital to dramatically cut caesarean rates". Chicago Tribune. Retrieved 2018-12-28.
  21. ↑ Gleicher, Norbert (February 2001). "Reducing risk of multiple pregnancy after ovarian stimulation with gonadotropins". ACOG Clinical Review. 6 (1): 6. doi:10.1016/S1085-6862(01)80011-X. ISSN   1085-6862.
  22. ↑ Barad, David H.; Gleicher, Norbert (September 2005). "Increased oocyte production after treatment with dehydroepiandrosterone". Fertility and Sterility. 84 (3): 756.e1–756.e3. doi:10.1016/j.fertnstert.2005.02.049. ISSN   0015-0282. PMID   16169414.
  23. 1 2 Torbati, Yeganeh. "How a renowned fertility doctor profits from an unproven supplement," The Washington Post, July 30, 2023. Retrieved July 30, 2023.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.